Sterling Capital Management LLC Has $2.04 Million Stock Holdings in Corteva, Inc. $CTVA

Sterling Capital Management LLC decreased its position in shares of Corteva, Inc. (NYSE:CTVA) by 42.2% during the 1st quarter, Holdings Channel reports. The fund owned 24,393 shares of the company’s stock after selling 17,788 shares during the quarter. Sterling Capital Management LLC’s holdings in Corteva were worth $2,042,000 at the end of the most recent quarter.

Other large investors have also recently bought and sold shares of the company. JPL Wealth Management LLC acquired a new stake in Corteva in the third quarter worth $25,000. Garton & Associates Financial Advisors LLC bought a new position in shares of Corteva during the fourth quarter worth $27,000. Bank of Jackson Hole Trust acquired a new position in shares of Corteva in the 4th quarter valued at $28,000. Cornerstone Financial Management LLC acquired a new position in shares of Corteva in the 4th quarter valued at $29,000. Finally, Basepoint Wealth LLC bought a new stake in shares of Corteva in the 4th quarter valued at $30,000. Institutional investors own 81.54% of the company’s stock.

Corteva Stock Down 0.0%

Corteva stock opened at $82.60 on Monday. The company has a current ratio of 1.47, a quick ratio of 1.03 and a debt-to-equity ratio of 0.07. Corteva, Inc. has a 1-year low of $60.53 and a 1-year high of $85.63. The company has a fifty day simple moving average of $79.38 and a 200 day simple moving average of $76.28. The company has a market cap of $55.24 billion, a P/E ratio of 48.59, a price-to-earnings-growth ratio of 2.53 and a beta of 0.57.

Corteva (NYSE:CTVA) last issued its quarterly earnings results on Tuesday, May 5th. The company reported $1.50 EPS for the quarter, topping the consensus estimate of $1.18 by $0.32. Corteva had a net margin of 6.50% and a return on equity of 9.95%. The firm had revenue of $4.91 billion for the quarter, compared to analysts’ expectations of $4.64 billion. During the same period in the previous year, the firm posted $1.13 EPS. The company’s revenue for the quarter was up 11.0% on a year-over-year basis. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. Research analysts anticipate that Corteva, Inc. will post 3.72 earnings per share for the current fiscal year.

Corteva Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Monday, June 15th. Investors of record on Monday, June 1st were issued a dividend of $0.18 per share. This represents a $0.72 annualized dividend and a yield of 0.9%. The ex-dividend date was Monday, June 1st. Corteva’s dividend payout ratio is presently 42.35%.

Wall Street Analysts Forecast Growth

Several research firms have weighed in on CTVA. The Goldman Sachs Group lifted their target price on Corteva from $88.00 to $96.00 and gave the stock a “buy” rating in a report on Tuesday, April 14th. Jefferies Financial Group increased their price target on Corteva from $95.00 to $97.00 in a report on Thursday, May 7th. Rothschild & Co Redburn raised their price target on Corteva from $80.00 to $90.00 and gave the stock a “neutral” rating in a research report on Wednesday, April 29th. BNP Paribas Exane boosted their price objective on Corteva from $74.00 to $77.00 in a research report on Wednesday, May 6th. Finally, Royal Bank Of Canada increased their target price on Corteva from $95.00 to $97.00 and gave the stock an “outperform” rating in a research note on Thursday, May 7th. Fourteen equities research analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $88.81.

About Corteva

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.